| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Basho Chandan | COO and CFO | C/O ASTRANA HEALTH, INC., 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA | /s/ Kathy Diep, as Attorney-in-Fact | 09 Sep 2025 | 0001929126 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ASTH | Common Stock | Tax liability | $50,312 | -1,694 | -0.95% | $29.70 | 176,946 | 05 Sep 2025 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on September 5, 2025. |
| F2 | Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 7,214 shares, which will vest on April 14, 2026; and (ii) 30,404 shares, which will vest in two equal annual installments on May 16, 2026 and 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 23,404 restricted stock units, which will vest in six equal semi-annual installments beginning on October 2, 2025; and (ii) 23,364 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026. |